---
category: news
title: "Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC"
excerpt: "OnKai's AI models redefine the methodologies and economics of clinical trials. TEL AVIV, Israel, July 10, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (\"Galmed\""
publishedDateTime: 2023-07-10T13:44:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
webUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
type: article
quality: 14
heat: 14
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI
  - AI in Healthcare

secured: "S+ERh2qRTcaVRfHiSaXvU/l6jcwcA2HGvoOXwf7mqBeg3iSDzswZoVq5F8ijo0YAFTu+Co8GRB5YX3VB/7mM1JVeIuqv/3tjxhtVnfcc3FEIxTQAmhaUPBQD1kWrNjpVHD7o/p8fEDsRhUH9HARytT4WRVfbysauXC+XWCGDGktm55ZnnGzfyPzkX3RHwHmpXjszWmmmF7034hTxEz+oe+Hi+3no42ABxpx0uic9+fJYenOZrOEHyGb33SbmiZXDspvsv4gZsSbN/03Khe9LwAsQitwJCre/xHlvCH0ReLFvdxAGeDWB0/3XyXRqjre2PaRbugJF5f4LxuGKK45JieNK9Ixx2YDDQu1/dsfol1w=;5TF2737vb7wMVosTVBJH2A=="
---

